Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Helmholtz Zentrum München
Múnich, AlemaniaPublications en collaboration avec des chercheurs de Helmholtz Zentrum München (13)
2024
2022
-
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes
Diabetes/Metabolism Research and Reviews, Vol. 38, Núm. 3
2021
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
2020
-
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma
PLoS ONE, Vol. 15, Núm. 9 September
2019
-
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
SLAS Discovery, Vol. 24, Núm. 3, pp. 398-413
-
Epigenome-wide meta-analysis of DNA methylation and childhood asthma
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 6, pp. 2062-2074
2018
-
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Nature Communications, Vol. 9, Núm. 1
2016
-
T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
Gene Therapy, Vol. 23, Núm. 10, pp. 753-759
2014
-
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
Acta Neuropathologica, Vol. 128, Núm. 3, pp. 397-410
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine
2008
-
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model
Journal of Gene Medicine, Vol. 10, Núm. 2, pp. 177-186
2007
-
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Hepatology, Vol. 45, Núm. 3, pp. 602-613